Lipid peroxidation products as potential bioindicators of Lyme arthritis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 3, 2011, Pages 415-422

  Luczaj W ^a   Moniuszko, A ^a   Rusak, M ^a   Pancewicz, S ^a   Zajkowska, J ^a   Skrzydlewska, E ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; 8 ISOPROSTAGLANDIN F2 ALPHA; MALONALDEHYDE;

ADULT; AGED; ANAMNESIS; ARTICLE; BORRELIA BURGDORFERI; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID PEROXIDATION; LYME DISEASE; MALE; MASS SPECTROMETRY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; SEROLOGY;

ADULT; AGED; ALDEHYDES; ANTIBODIES, BACTERIAL; BLOTTING, WESTERN; BORRELIA BURGDORFERI; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; DINOPROST; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPID PEROXIDATION; LYME DISEASE; MALE; MALONDIALDEHYDE; MASS SPECTROMETRY; MIDDLE AGED;

EID: 79951727219     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-010-1102-0     Document Type: Article

References (32)

1. Steere AC (2001) Lyme disease. N Engl J Med 345:115-125
2. Asch ES, Bujak DI, Weiss M, Peterson MG, Weinstein A (1994) Lyme disease: an infectious and postinfectious syndrome. J Rheumatol 21:454-461 (Pubitemid 24102829)
3. Pancewicz SA, Skrzydlewska E, Hermanowska-Szpakowicz T, Zajkowska JM, Kondrusik M (2001) Role of reactive oxygen species (ROS) in patients with erythema migrans, an early manifestation of Lyme borreliosis. Med Sci Monit 7:1230-1235 (Pubitemid 33138170)
4. Uesugi M, Yoshida K, Jasin HE (2000) Inflammatory properties of IgG modified by oxygen radicals and peroxynitrite. J Immunol 165:6532-6537
5. Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81-128 (Pubitemid 121003917)
6. Barclay LRC (1993) Quantitative studies of peroxidation, antioxidant action, partitioning and oxidative stress. Can J Chem 71:1-16
7. Montuschi P, Barnes PJ, Roberts LJ 2nd (2004) Isoprostanes: markers and mediators of oxidative stress. FASEB J 18:1791-1800 (Pubitemid 39602265)
8. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87:9383-9387
9. Milne GL, Yin H, Morrow JD (2008) Human biochemistry of the isoprostane pathway. J Biol Chem 283:15533-15537
10. 2-isoprostanes in human urine. Proc Natl Acad Sci USA 96:13381-13386
11. Londero D, Lo Greco P (1996) Automated high-performance liquid chromatographic separation with spectrofluorometric detection of a malondialdehyde-thiobarbituric acid adduct in plasma. J Chromatogr A 729:207-210 (Pubitemid 26135017)
12. Yoshino K, Matsuura T, Sano M, Saito SCh, Tomita I (1986) Fluorometric liquid chromatographic determination of aliphatic aldehydes arising from lipid peroxides. Chem Pharm Bull 34:1694-1700
13. Bradford A, Atkinson J, Fuller N, Rand RP (2003) The effect of vitamin E on the structure of membrane lipid assemblies. J Lipid Res 44:1940-1945 (Pubitemid 37356666)
14. Kinter M, Roberts RJ (1996) Glutathione consumption and glutathione peroxidase inactivation in fibroblast cell lines by 4-hydroxy-2-nonenal. Free Radic Biol Med 21:457-462 (Pubitemid 26313941)
15. Dotan Y, Lichtenberg D, Pinchuk I (2004) Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lipid Res 43:200-227 (Pubitemid 38299193)
16. Buczynski MW, Dumlao DS, Dennis EA (2009) Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology. J Lipid Res 50:1015-1038
17. Blaho VA, Buczynski MW, Brown CR, Dennis EA (2009) Lipidomic analysis of dynamic eicosanoid responses during the induction and resolution of Lyme arthritis. J Biol Chem 284:21599-21612
18. Yin H, Morrow JD, Porter NA (2004) Identification of a novel class of endoperoxides from arachidonate autoxidation. J Biol Chem 279:3766-3776
19. Yin H, Havrilla CM, Gao L, Morrow JD, Porter NA (2003) Mechanisms for the formation of isoprostane endoperoxides from arachidonic acid. "Dioxetane" intermediate versus beta-fragmentation of peroxyl radicals. J Biol Chem 278:16720-16725
20. Morrow JD, Chen Y, Brame CJ, Yang J, Sanchez SC, Xu J, Zackert WE, Awad JA, Roberts LJ (1999) The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation. Drug Metab Re 1:117-139
21. 2s and lipid peroxidation. Biochim Biophys Acta 1488:167-181
22. Blaho VA, Mitchell WJ, Brown CR (2008) Arthritis develops but fails to resolve during inhibition of cyclooxygenase 2 in a murine model of Lyme disease. Arthritis Rheum 58:1485-1495 (Pubitemid 351705938)
23. Katsuki H, Okuda S (1995) Arachidonic acid as a neurotoxic and neurotrophic substance. Prog Neurobiol 46:607-636
24. Coolen SA, van Buuren B, Duchateau G, Upritchard J, Verhagen H (2005) Kinetics of biomarkers: biological and technical validity of isoprostanes in plasma. Amino Acids 29:429-436
25. Foulks JM, Marathe GK, Michetti N, Stafforini DM, Zimmerman GA, McIntyre TM, Weyrich AS (2009) PAF-acetylhydrolase expressed during megakaryocyte differentiation inactivates PAF-like lipids. Blood 113:6699-6706
26. McIntyre TM, Prescott SM, Stafforini DM (2009) The emerging roles of PAF acetylhydrolase. J Lipid Res 50:S255-S259
27. Ito S, Noguchi E, Shibasaki M, Yamakawa-Kobayashi K, Watanabe H, Arinami T (2002) Evidence for an association between plasma platelet-activating factor acetylhydrolase deficiency and increased risk of childhood atopic asthma. J Hum Genet 47:99-101 (Pubitemid 34296663)
28. Satoh N, Asano K, Naoki K, Fukunaga K, Iwata M, Kanazawa M, Yamaguchi K (1999) Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma. Am J Respir Crit Care Med 159:974-979 (Pubitemid 29137804)
29. Stafforini DM (2009) Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2). Cardiovasc Drugs Ther 23:73-83
30. 2α is generated from the isoprostane pathway and not the cyclooxygenase in humans. J Biol Chem 282:329-336
31. Frölich JC, Wilson TW, Sweetman BJ, Smigel M, Nies AS, Carr K, Watson JT, Oates JA (1975) Urinary prostaglandins. Identification and origin. J Clin Invest 55:763-770
32. 2α in different rheumatic diseases. Ann Rheum Dis 2001 60:627-631